These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 12112064)

  • 1. Rabbit model of Guillain-Barré syndrome.
    Nachamkin I
    Ann Neurol; 2002 Jul; 52(1):127-8; author reply 128-9. PubMed ID: 12112064
    [No Abstract]   [Full Text] [Related]  

  • 2. Validation of a rabbit model of neuropathy induced by immunization with gangliosides.
    Moyano AL; Comín R; Lardone RD; Alaniz ME; Theaux R; Irazoqui FJ; Nores GA
    J Neurol Sci; 2008 Sep; 272(1-2):110-4. PubMed ID: 18573503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental Guillain-Barre syndrome induced by immunization with gangliosides: Keyhole limpet hemocyanin is required for disease triggering.
    Funes SC; Chiari ME; Comín R; Irazoqui FJ; Nores GA
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1473-1478. PubMed ID: 28188832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental axonopathy induced by immunization with Campylobacter jejuni lipopolysaccharide from a patient with Guillain-Barré syndrome.
    Caporale CM; Capasso M; Luciani M; Prencipe V; Creati B; Gandolfi P; De Angelis MV; Di Muzio A; Caporale V; Uncini A
    J Neuroimmunol; 2006 May; 174(1-2):12-20. PubMed ID: 16516981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aspects of the etiopathogenesis of experimental allergic neuritis].
    Varsik P
    Cesk Neurol Neurochir; 1980 May; 43(3):148-54. PubMed ID: 7397866
    [No Abstract]   [Full Text] [Related]  

  • 6. [Methodical modifications to optimize granulomatous lung changes in animal experiment (author's transl)].
    Eckert H; Lux M; Szymanska D
    Z Erkr Atmungsorgane; 1981 May; 157(2):230-2. PubMed ID: 7314698
    [No Abstract]   [Full Text] [Related]  

  • 7. [Alveolar proteinosis].
    Ito F
    Nihon Rinsho; 1972 Jan; 30(1):125-6. PubMed ID: 4338968
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immune damage to the heart and blood vessels].
    Moĭbenko AA; Butenko GM
    Fiziol Zh (1978); 1981; 27(5):587-94. PubMed ID: 7297706
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of adjuvant monarthritis is critically dependent on the induction protocol: comment on the article by Busso et al.
    Ferrell W; Kelso E; Lockhart J; Dunning L
    Arthritis Rheum; 2007 Oct; 56(10):3510. PubMed ID: 17907181
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple sclerosis-like disease induced in rabbits by immunization with brain gangliosides.
    Cohen O; Sela BA; Schwartz M; Eshhar N; Cohen IR
    Isr J Med Sci; 1981 Aug; 17(8):711-4. PubMed ID: 7287414
    [No Abstract]   [Full Text] [Related]  

  • 11. Collagen-induced arthritis.
    Brand DD; Latham KA; Rosloniec EF
    Nat Protoc; 2007; 2(5):1269-75. PubMed ID: 17546023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Axonal Guillain-Barré syndrome and physiological role of gangliosides in saltatory conduction of myelinated nerve fibers].
    Susuki K; Yuki N
    Tanpakushitsu Kakusan Koso; 2004 Nov; 49(15 Suppl):2479-84. PubMed ID: 15553005
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of parenteral administration of mineral oil adjuvant in parturient cattle on immunoglobulin secretion in colostrum and milk.
    De Cueninck BJ
    Am J Vet Res; 1981 Mar; 42(3):478-80. PubMed ID: 7271013
    [No Abstract]   [Full Text] [Related]  

  • 14. The Guillain-Barré syndrome: a true case of molecular mimicry.
    Ang CW; Jacobs BC; Laman JD
    Trends Immunol; 2004 Feb; 25(2):61-6. PubMed ID: 15102364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sialic acid residue is a crucial component of C. jejuni lipooligosaccharide ganglioside mimicry in the induction Guillain-Barré syndrome.
    Xiang SL; Zhong M; Cai FC; Deng B; Zhang XP
    J Neuroimmunol; 2006 May; 174(1-2):126-32. PubMed ID: 16567003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive and curative effects of cyclophosphamide in an animal model of Guillain Barrè syndrome.
    Mangano K; Dati G; Quattrocchi C; Proietti L; Mazzarino C; Di Marco R; Bendtzen K; Greco B; Zaratin P; Nicoletti F
    J Neuroimmunol; 2008 May; 196(1-2):107-15. PubMed ID: 18452999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guillain-Barré and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy.
    Shin IS; Baer AN; Kwon HJ; Papadopoulos EJ; Siegel JN
    Arthritis Rheum; 2006 May; 54(5):1429-34. PubMed ID: 16645971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High affinity of anti-GM1 antibodies is associated with disease onset in experimental neuropathy.
    Comín R; Yuki N; Lopez PH; Nores GA
    J Neurosci Res; 2006 Oct; 84(5):1085-90. PubMed ID: 16881049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete Freund's adjuvant-induced intervertebral discitis as an animal model for discogenic low back pain.
    Lee M; Kim BJ; Lim EJ; Back SK; Lee JH; Yu SW; Hong SH; Kim JH; Lee SH; Jung WW; Sul D; Na HS
    Anesth Analg; 2009 Oct; 109(4):1287-96. PubMed ID: 19762759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement inhibitor prevents disruption of sodium channel clusters in a rabbit model of Guillain-Barré syndrome.
    Phongsisay V; Susuki K; Matsuno K; Yamahashi T; Okamoto S; Funakoshi K; Hirata K; Shinoda M; Yuki N
    J Neuroimmunol; 2008 Dec; 205(1-2):101-4. PubMed ID: 18973956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.